Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacodynamics Study”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02583594
What this trial is testing

Characterize Subcutaneous or Intravenous Alemtuzumab in Patients With Progressive Multiple Sclerosis

Who this might be right for
Progressive Multiple Sclerosis
Genzyme, a Sanofi Company 24
Early research (Phase 1)Study completedNCT01818869
What this trial is testing

To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses AZD8848 in Healthy Subjects

Who this might be right for
Safety,Tolerability,Healthy Subjects
AstraZeneca 8
Early research (Phase 1)Looking for participantsNCT06946641
What this trial is testing

A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients

Who this might be right for
Atopic DermatitisHidradenitis Suppurativa (HS)Rheumatoid Arthritis (RA)
Shanghai Qilu Pharmaceutical Research and Development Center LTD 102
Early research (Phase 1)Study completedNCT05466422
What this trial is testing

MK-2214 in Adults With Mild Cognitive Impairment or Mild-to-Moderate Alzheimer's Disease (MK-2214-002)

Who this might be right for
Alzheimer Disease
Merck Sharp & Dohme LLC 34
Early research (Phase 1)Study completedNCT03647228
What this trial is testing

A Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of IONIS-ENaCRx in Healthy Volunteers and Patients With Cystic Fibrosis

Who this might be right for
Healthy SubjectsCystic Fibrosis
Ionis Pharmaceuticals, Inc. 98
Early research (Phase 1)Study completedNCT03235219
What this trial is testing

A Phase 1b Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of JNJ-64565111 in Participants With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 39
Early research (Phase 1)Study completedNCT02207595
What this trial is testing

Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profiles of UCB5857 in Healthy Subjects

Who this might be right for
Healthy Volunteers
UCB Celltech 60
Early research (Phase 1)Ended earlyNCT00943371
What this trial is testing

A Single-Dose Study of MK6349 in Patients With Type 2 Diabetes (6349-002)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 28
Early research (Phase 1)Study completedNCT05262595
What this trial is testing

Look at How Insulin NNC0471-0119 Works in the Body in People With Type 1 Diabetes When Injected by Insulin Pump

Who this might be right for
Diabetes Mellitus, Type 1
Novo Nordisk A/S 19
Early research (Phase 1)Ended earlyNCT01965600
What this trial is testing

Evaluate The Safety And Effects On The Body Of An Investigational Drug Using An Endotoxin-Induced Inflammatory Response Model

Who this might be right for
Healthy
Pfizer 23
Early research (Phase 1)Study completedNCT02426151
What this trial is testing

Bioequivalence of a Single Subcutaneous Dose of BEPO and REPO in Healthy Male Subjects

Who this might be right for
Healthy
LG Life Sciences 46
Early research (Phase 1)Study completedNCT01273571
What this trial is testing

A Pharmacokinetic and Pharmacodynamic Study of Metformin and Canagliflozin in Healthy Adult Volunteers

Who this might be right for
Healthy
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 18
Testing effectiveness (Phase 2)UnknownNCT05602792
What this trial is testing

T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorSarcomaHNSCC+4 more
ImmVira Pharma Co. Ltd 233
Early research (Phase 1)Looking for participantsNCT07767175
What this trial is testing

A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity

Who this might be right for
OverweightObesity
Novo Nordisk A/S 142
Early research (Phase 1)Study completedNCT01060475
What this trial is testing

Safety and Tolerability of LIM-0705 in Healthy Male Subjects

Who this might be right for
Healthy
Limerick BioPharma 44
Testing effectiveness (Phase 2)Study completedNCT06309277
What this trial is testing

A Clinical Study to Evaluate of Single and Multiple Oral Doses of GM-1020 in Patients With MDD

Who this might be right for
Major Depressive Disorder
Gilgamesh Pharmaceuticals 46
Early research (Phase 1)Study completedNCT01290575
What this trial is testing

Multiple Ascending Dose Study of BMS-820132 in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Bristol-Myers Squibb 67
Early research (Phase 1)Study completedNCT02169453
What this trial is testing

Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/Carbidopa

Who this might be right for
Parkinson's Disease (PD)
Bial - Portela C S.A. 12
Early research (Phase 1)Study completedNCT01898364
What this trial is testing

Safety and Efficacy Evaluation of Repeat neoGAA Dosing in Late Onset Pompe Disease Patients.

Who this might be right for
Pompe DiseaseGlycogen Storage Disease Type II (GSD II)Acid Maltase Deficiency
Genzyme, a Sanofi Company 24
Early research (Phase 1)Study completedNCT04302064
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single-Ascending and Multiple Doses of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Healthy Japanese Participants

Who this might be right for
Healthy Participants
Ionis Pharmaceuticals, Inc. 24
Next Page